 |
1. Welcome |
|
|
2. HIV Breakfast Club |
|
|
3. HIV Breakfast Club Acknowledgements |
|
|
4. HIV Breakfast Club |
|
|
5. Ghost of Old River |
|
|
6. Anatomy of the Anus |
|
|
7. Normal anorectal transition zone |
|
|
8. Anal carcinoma and HIV: |
|
|
9. Anal CA and HIV (con’t): |
|
|
10. HIV-Associated Anal Cancer: Has Highly Active Antiretroviral Therapy Reduced the Incidence or Improved the Outcome? |
|
|
11. Background and Rationale |
|
|
12. Summary of Study Design |
|
|
13. Anal Cancer Incidence |
|
|
14. Anal Cancer Survival |
|
|
15. Key Conclusions |
|
|
16. Sharp Rise in Anal Malignancies |
|
|
17. Sharp Rise in Anal Malignancies Identified in French Hospitals Not Affected by HAART |
|
|
18. Sharp Rise in Anal Malignancies Identified in French Hospitals Not Affected by HAART (cont) |
|
|
19. Sharp Rise in Anal Malignancies Identified in French Hospitals Not Affected by HAART (cont) |
|
|
20. Sharp Rise in Anal Malignancies Identified in French Hospitals Not Affected by HAART (cont) |
|
|
21. Sharp Rise in Anal Malignancies Identified in French Hospitals Not Affected by HAART (cont) |
|
|
22. Sharp Rise in Anal Malignancies Identified in French Hospitals Not Affected by HAART (cont) |
|
|
23. Trends in HIV Care |
|
|
24. Slide 24 |
|
|
25. Evaluation of Anal Cancer in HIV+ Patients |
|
|
26. Incidence of Anal Cancer Increasing Despite HAART |
|
|
27. Slide 27 |
|
|
28. Anal Pap Smear |
|
|
29. Slide 29 |
|
|
30. Slide 30 |
|
|
31. Slide 31 |
|
|
32. Risk factors for anal carcinoma |
|
|
33. Risk factors for Anal Carcinoma in HIV+ patients: |
|
|
34. HPV and anal dysplasia |
|
|
35. Terms used in anal dysplasia |
|
|
36. Grades of anal squamous intraepithelial neoplasia |
|
|
37. Anal dysplasia flow chart |
|
|
38. Low grade dysplasia/condylomata |
|
|
39. External anal condylomata |
|
|
40. Anal carcinoma |
|
|
41. Slide 41 |
|
|
42. Other signs & symptoms for developing anal CA: |
|
|
43. Slide 43 |
|
|
44. Clinical question: |
|
|
45. Methods: |
|
|
46. Methods (cont): |
|
|
47. Results |
|
|
48. Results |
|
|
49. Results |
|
|
50. Results |
|
|
51. Results: statistically significant findings |
|
|
52. Results: comparing significant findings |
|
|
53. Results: statistical trends |
|
|
54. Slide 54 |
|
|
55. Slide 55 |
|
|
56. Slide 56 |
|
|
57. Results: non statistically significant findings |
|
|
58. Results: non statistically significant findings |
|
|
59. Conclusions |
|
|
60. Sensitivity/specificity of anal paps: |
|
|
61. Anal pap smears: precision |
|
|
62. Study limitations: |
|
|
63. Future in testing for anal CA in the HIV population |
|
|
64. The End |
|
